Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | BIRC3 | Q13489 | 3/20 | 0.37 |
| ▸ | XIAP | P98170 | 2/20 | 0.37 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 7/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TERF2 | Q15554 | 3/20 | 0.35 |
| ▸ | PLG | P00747 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16349811 | 0.88 | F2 (0.42) | F2F10PRSS1BIRC3XIAP | |
| SCHEMBL12856080 | 0.87 | F2 (0.35) | F2F10PRSS1GAAPLG | |
| SCHEMBL8291443 | 0.87 | F2 (0.43) | F2F10PRSS1BIRC3XIAP | |
| SCHEMBL13685100 | 0.82 | F2 (0.33) | F2F10PRSS1GAAPLG | |
| SCHEMBL12856032 | 0.81 | PPIA (0.38) | HDAC1HDAC4GAATERF2 | |
| SCHEMBL8291408 | 0.80 | ADAM17 (0.38) | BIRC3 | |
| SCHEMBL13685619 | 0.79 | TERF2 (0.40) | BIRC3XIAPBIRC2TERF2 | |
| SCHEMBL13685776 | 0.78 | TERF2 (0.41) | BIRC3XIAPBIRC2HDAC1HDAC4 | |
| SCHEMBL1645089 | 0.78 | F2 (0.37) | F2F10PRSS1BIRC3XIAP | |
| SCHEMBL1655875 | 0.78 | BIRC3 (0.38) | F2F10PRSS1BIRC3XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005030796-A1 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE | SCHERING CORPORATION (US) | 2005-04-07 | — | — | WO | disclosed |